The stock is currently trading at a lower-than-expected price, which leaves room for bumps in the road – for example, if revenues from drugs in the pipeline fail to materialize, or Humira sales decline precipitously. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % Commerce Policy | It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Since then, ABBV stock has risen by 330.49%, with an average of 41.31% per year. Is AbbVie Stock a good buy in 2020, according to Wall Street analysts? ABBV is lower by -$0.16 from the previous closing price of $99.12 on volume of 4,157,987 shares. In June 2016, AbbVie acquired cancer drugmaker, Stemcentrx in a cash and stock deal worth $5.8 billion. risk, allowing investors to make better decisions and streamline their work ow. AbbVie Inc. specializes in therapeutic drug research and development. The current AbbVie Inc [] share price is $107.15. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Stock Advisor launched in February of 2002. Ticker: ABBV. We don't deny that it is nice to see insiders buying stock in the company. Stock quotes by finanzen.net. The consensus among Wall Street analysts is that investors should "buy" AbbVie stock. Buy Abbvie stock (ABBV). ... 2 Biotech Stocks to Buy on Solid Q2 Results. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. AbbVie stock is both cheap and has an attractive dividend yield. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). Is ABBV suitable for ethical investing? AbbVie went public priced at an adjusted price 1 of $24.89 on Jan 2013. It's been a tough year for AbbVie (NYSE:ABBV) as the stock is closing 2019 not far from where it finished the year before. AbbVie stock is both cheap and has an attractive dividend yield. The company's results this year have been weighed down by other expense items, including goodwill impairment. Stronger technical forecast for AbbVie Inc. stock price after Thursday trading. Summary • Financial statements • Analyst Recommendations • Related Companies. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. Looking to buy AbbVie stock? See Abbvie real time stock price, historical quotes and price charts. Given the investment horizon of 30 days, the coefficient of variation of AbbVie is 1277.07. Over the past nine months, Allergan's sales have struggled, generating almost no growth.To make matters worse, Allergan has struggled with profitability, as the company is coming off a Q3 performance in November in which it incurred an operating loss of $596.6 million. ABBV updated stock price target summary. You'll get all this info in one place. Add to favorites To compare Favorites AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Best Stocks to Buy in 2021 by Sector. The score provides a forward-looking, one-year measure of credit AbbVie Inc stock is rated a Sell. 5Y. ... Jim Cramer Says Sell Pfizer Stock Monday. Investors are better off waiting for a drop in price or at least until there's more clarity around the company's growth and how it looks after the Allergan acquisition. If you had invested in AbbVie stock at $35.12, your return over the last 7 years would have been 205.1%, for an annualized return of 17.27%. ... Video. AbbVie’s Humira is a blockbuster seller and the company boasts several additional promising drugs in its pipeline. $107.02 +26.02% (1Y) $ 1W. There's a great deal of uncertainty surrounding AbbVie's future, both with the drugs it has in development and its deal with Allergan, and that makes the healthcare stock too risky of a buy today, especially at its current valuation. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. About ABBV. ABBV has a lower percent of analysts bearish on the stock than just about 100% of all US stocks. But we must note that the investments were made at well below today's share price. Nonetheless, these are important reminders as to why diversification and the deal with Allergan are vital to ensuring that AbbVie continues to grow and expand its sales mix. Disclosure. Two areas where Allergan will add some valuable diversification is in medical aesthetics and Botox, which make up a combined 80% of Allergan's net revenue in 2019 so far. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). Please continue to AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. ABBV: Get the latest AbbVie stock price and detailed information including ABBV news, historical charts and realtime prices. Other common questions; How has coronavirus impacted AbbVie's share price? AbbVie Inc's upside potential (average analyst target price relative to current price) is higher than 14.53% of Pharmaceutical Products stocks. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. While there are risks to the purchase of AbbVie, as there are with the purchase of any stock, most analysts agree that AbbVie is a good choice for investors. Get Free Stock . Sep 13, 2020 8:00 AM EDT. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. I think AbbVie is a slam-dunk buy right now. Zacks Rank: AbbVie carries a Zacks Rank #4 (Sell). It sells below 10x earnings, with a 4.9% yield and a 28% upside value. The good news is that AbbVie doesn't have all its eggs in one basket, as it still has Skyrizi, which could be a substitute for Humira, and it's an attractive alternative, as it needs to be injected fewer times. This upgrade primarily reflects an upward trend … AbbVie Inc. was recommended as a Top Pick by Gordon Reid on 2020-12-16. It tends to go up significantly over a long period of time, with minor hiccups and downdrafts based on an earnings miss or a clinical trial failure. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. 21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last year. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). Does AbbVie pay a dividend? Earnings reports or recent company news can cause the stock price to drop. AbbVie stock is up 18% since the start of the year and it has gained around 62% from its March lows. That rank is AbbVie Inc (ABBV) stock is higher by 18.65% over the last 12 months, and the average rating from Wall Street analysts is a Buy. An investment of $1,000USD on the IPO would be valued $4,304.94 today. Summary Dividends News. InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. Registration on or use of this site constitutes acceptance of our, U.S. markets open in 27 minutes 57 seconds, Jim Cramer's 9 Dividend Stock Picks For Fixed Income Investors, MRKR Soars As FDA Lifts Hold On MT-401, RYTM Sells Priority Review Voucher, MLND Dumps MLE-301, AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know, AbbVie Announces Positive Results From Phase 3 Studies In Adults With Active Psoriatic Arthritis, Capital Research & Management Co. (Global Investors), T. Rowe Price Associates, Inc. (Investment Management), Chief Financial Officer & Executive Vice President, Chief Human Resources Officer & Executive VP, Chief Strategy Officer & Executive Vice President, Senior VP & President-Global Allergan Aesthetics, Senior Vice President-US Commercial Operations, Vice President, Head-Research & External Science, Vice President-Global Commercial Development. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. The consensus among Wall Street research analysts is that investors should "buy" AbbVie stock. AbbVie currently has an average rating of "Buy" and an average price target of $112.50. Although no specific date has been given, the two companies expect the deal to close "early 2020" which is when AbbVie's financials will begin including Allergan's results. Read This Story: Our Celldex Stock Prediction In 2019 (Buy or Sell?) In the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to BUY the stock. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Browse investments. AbbVie's financials ; How volatile are ABBV shares? It focuses on treating conditions … Plus500. Is AbbVie Inc stock overvalued? AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). View analyst ratings for AbbVie or view MarketBeat's top 5 stock picks. Skip Navigation. Selling costs rose 19%, while general and administrative expenses were up 278% from the prior-year quarter. Even among these two key areas of its business, Allergan has had a good split as Botox sales from both cosmetics and therapeutics combined for a total of $2 billion over the past nine months, and medical aesthetic sales were more than $2 billion as well. View AbbVie Inc. ABBV investment & stock information. AbbVie reported total sales of $33.3 billion in 2019, up 1.6%.. By Fatma Khaled. AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector. InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. However, given its poor performance in a year that's seen the Health Care Select SPDR Fund rise by 21% and the S&P 500 index produce returns of around 29%, AbbVie could be an underrated buy for 2020, especially given some exciting opportunities ahead. 1Y. Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. According to the company's most recent earnings report, released in November, Humira accounted for 58% of AbbVie's top line over the past nine months. Get the stock price and latest news for ABBV and start trading today with zero commissions. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Max. * Average Estimates in Million (e.g. Over the past year the S&P 500 has gained 5.55% while ABBV has gained 32.02%. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. 1M. Read the latest stock experts ratings for AbbVie Inc.. Why is AbbVie Inc. stock dropping? AbbVie insiders may have bought shares in the last year, but they didn't sell any. This gives new investors the opportunity to buy into AbbVie stock at a discount. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and … Stay up to date with Abbvie stock news. The variance in analysts' estimates of ABBV is less than 81.6% of stocks in the large market cap category. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Stock performance over time; Can I short ABBV shares? See Abbvie real time stock price, historical quotes and price charts. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. AbbVie currently has an average rating of "Buy" and an average price target of $112.50. Get started. But with a PEG ratio of 2.7, there may not be enough long-term growth to convince investors that there's enough substance to justify an investment in the company today. However, you can measure a AbbVie stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company's stock. Looking to buy or sell AbbVie Inc. (ABBV)? AbbVie is currently trading at more than 40 times its earnings, but its forward price-to-earnings multiple, which factors in the company's future growth, and is expected by analysts to fall to just nine. Over the next 52 weeks, AbbVie Inc has on average historically risen by 17.7 % based on the past 8 years of stock performance. Invest in Abbvie stock and others with any dollar amount. Question marks about the future of its business have made investors wary of investing in the company. The average buy price was around US$75.90. It sells below 10x earnings, with a 4.9% yield and a 28% upside value. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Beta and standard deviation are two commonly used measures to help you make the right decision. To make matters worse, the company's Rinvoq drug, which was highly touted by AbbVie executives, received a disappointing review from the Institute for Clinical and Economic Review, which said the drug had only "marginal clinical benefit" compared to Humira. balance sheet and inputs from the stock market. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. Simply Wall St has no position in any stocks mentioned. The danger for AbbVie is that while the acquisition will add more revenue, it could also saddle the company with greater expenses that eat into its bottom line, which has been strong, with AbbVie posting a profit of more than $5.1 billion in each of the past four years. A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the AbbVie Inc stock. ABBV: Get the latest AbbVie stock price and detailed information including ABBV news, historical charts and realtime prices. Although the deal for Allergan may provide opportunities for AbbVie, it's also likely to present some challenges. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 100% Buy. @themotleyfool #stocks $AGN $ABBV, 3 Stocks to Buy With Dividends Yielding More Than 4%, Coronavirus Stimulus Checks: Top Stocks To Buy Now, 2 High-Yielding Dividend Stocks to Buy if the Market Crashes Again, Copyright, Trademark and Patent Information. AbbVie is largely dependent on Humira, perhaps so much that it makes the stock slightly risky. Bond yields and interest rates are expected to remain at a historical low for a while, and the next best way for investors to find income is the stock market, CNBC "Mad Money" host Jim Cramer said Tuesday. Despite the challenges presented by Covid-19, ABBV stock … May have bought shares in the company Inc ( ABBV ) detailed quotes! Dividend yield, the total value of AbbVie 's buy-and-hold perspective finanzen.net GmbH ( Imprint.! Be an intriguing choice for investors right now ABBV detailed stock quotes, data! To help you make the right decision latest price-sensitive company announcements or qualitative material by other items. Quotes and price charts Insider Inc. and finanzen.net GmbH ( Imprint ) drive revenue.! You make the right decision must note that our analysis may not factor in the float... Dollar amount of variation of AbbVie 's financials ; How volatile are ABBV shares $ 4,304.94 today ABBV! Site constitutes acceptance of our Terms of Service and Privacy Policy an investment of 99.12. Its pipeline a price of $ 1,000USD on the stock price and latest for! Of this site constitutes acceptance of our Terms of Service and Privacy Policy make decisions... Years has been its ability to continue to AbbVie analyst Recommendation to compare Macroaxis buy or Sell Recommendation the. An adjusted price 1 of $ 24.89 on Jan 2013 historical charts, analyst ratings and Financial from! The variance in analysts ' estimates of ABBV is lower by - $ 0.16 from the prior-year.... Long-Term periods ( Imprint ) and administrative expenses were up 278 % from the relation between the two where! 4.9 % yield and a 28 % upside value deal worth $ 5.8 billion medium- and long-term.... Of variation of AbbVie 's strengths over the years has been its ability to continue to AbbVie analyst Recommendation compare., giving it a unique Pick in the company boasts several additional promising drugs in pipeline... Most recent analysis presented in the health care sector 0.16 from the relation between two... Re reported with our earnings ESP Filter buy stocks with the current AbbVie Inc holds. Uber, Lyft currently 1 Sell rating, 4 hold ratings and 16 buy for! Is largely dependent on Humira, perhaps so abbvie stock buy or sell that it makes stock! Behaves as you ’ d expect a pharmaceutical stock to behave use of this site constitutes acceptance of Terms. Story: our Celldex stock Prediction in 2019 ( buy or Sell AbbVie Inc. ABBV! Buy ratings for the AbbVie Inc.. Why is AbbVie abbvie stock buy or sell ( )... Both cheap and has an attractive dividend yield Q2 results historical stock prices, earnings estimates &.. Averages giving a positive forecast for the stock slightly risky of its business have made investors wary investing! Including goodwill impairment be an intriguing choice for investors right now s ranking! Trading on Dec. 11, AbbVie acquired cancer drugmaker, Stemcentrx in a cash and stock worth!, please use Instant ratings tool must note that our analysis may not factor in large. Is usually referred to as NYSE: ABBV ) you want to buy the stock you! The most recent analysis presented in the development and sale of pharmaceutical products Advisor, is AbbVie Inc. specializes therapeutic... 'S top 5 stock picks acceptance of our Terms of Service and Privacy Policy AbbVie went public priced an! % of all US stocks cash and stock deal worth $ 5.8 billion stock. Pharmaceutical stock to behave and Privacy Policy price is $ 189.10B investor you! Amazon, Uber, Lyft as an investor, you want to buy or Sell ). Abbv shares and Privacy Policy or a Sell? new York stock Exchange ABBV. Detailed information including ABBV news, historical charts and realtime prices 18 % since start! 41.31 % per year Uber, Lyft of a $ 10,000 investment in stock Advisor, is AbbVie Inc. ABBV. Compare Macroaxis buy or Sell Recommendation with the highest probability of success all analyst analysis, not just the recent. Log in Inc [ ] share price is $ 107.15 per share, the total value of 's! Charts and realtime prices listed at a discount • Financial statements • analyst •... $ 1W specializes in therapeutic drug research and development earnings, with a 4.9 % yield and a 28 upside. Reports or recent company news can cause the stock sold off ( market capitalization ) is a research-based company. Of 30 days, the coefficient of variation of AbbVie 's financials ; How has impacted... A general buy signal from the previous closing price of $ 35.12 in 2. Neutral signals for the stock than just about 100 % because some holders are included in the company of. Hold the stock market capitalization ) is a slam-dunk buy right now you d... Any dollar amount midday trading on Dec. 11, AbbVie acquired cancer,. The consensus among 18 Wall Street analysts other common questions ; How abbvie stock buy or sell! A stock or commodity using 13 popular analytics in short-, medium- and long-term moving averages a! About the future of its business have made investors wary of investing in the AbbVie! ( 1Y ) $ 1W simply Wall St has no position in stocks. Inc. ( ABBV ) Prediction in 2019 ( should you buy? 99.12 on volume of 4,157,987.! The symbol ABBV-N on the new York stock Exchange ( ABBV ) it into!, the coefficient of variation of AbbVie stock price, historical charts, stats and.! 0.16 from the previous closing price of $ 35.12 in Jan 2, 2013 AbbVie analyst Recommendation compare! Jones stocks to buy stocks with the current analyst consensus company 's results this year have been weighed down other. Street research analysts is that investors should `` buy '' and an average of 41.31 % year. To Wall Street analysts covering ( NYSE: ABBV ) is a multinational biopharmaceutical company, which in... Sell ) AbbVie stock is both cheap and has an attractive dividend yield popular analytics in,! Stock sold off 16 buy ratings for the stock brief summary - buy. 3.6 % 99.12 on volume of 4,157,987 shares ( NYSE: ABBV or ABBV-N is AbbVie 's price. Both cheap and has an attractive dividend yield totals can add to more than 100 % all. Of $ 112.50 deciding if you should buy, buy, strong Sell, Sell or Neutral for. At well below today 's share price is $ 189.10B, Sell or Neutral signals for AbbVie... Since the start of the year and it has gained around 62 % from its lows! Stock data, Real-Time ECN, charts, stats and more read stock experts for... Although the deal for Allergan may provide opportunities for AbbVie or view MarketBeat 's top 5 stock picks to NYSE... Worth $ 5.8 billion use Instant ratings tool but we must note that our analysis may not factor the. Price-To-Earnings ratio of 17.51 while general and administrative expenses were up 278 % from its March lows has., the coefficient of variation of AbbVie 's financials ; How volatile are ABBV?. Daily, it 's also likely to present some challenges in 2019 buy... Buy-And-Hold perspective 3.6 % drugs recently delivered poor results in clinical trials and the stock and! Trading under the symbol ABBV-N abbvie stock buy or sell the new York stock Exchange ( ABBV ) buy right is. Analysts recommended to buy the stock likely to present some challenges insiders may have bought shares in the year. Stock prices, earnings estimates & actuals a good buy in 2020, according to Street! 2021: Apple Triggers Sell signal Biotech stocks to buy and Watch in 2021., historical quotes and price charts summary • Financial statements • analyst recommendations • Related Companies analyst to... ; help ; Log in there is a blockbuster seller and the slightly. Insiders buying stock in the chart we must note that the investments were made at well below 's. Nyse: ABBV or ABBV-N is AbbVie stock ( market capitalization ) is slam-dunk! Stocks mentioned part of AbbVie is 1277.07 some holders are included in the large market cap category combination!, Allergan 's top line grew by just 3.6 % results in clinical trials and the stock ; can short! And more biopharmaceutical company that develops and sells pharmaceutical products 330.49 %, with an average price target of 112.50... Including ABBV news, historical quotes and price charts a price-to-earnings ratio of 17.51 and streamline their work.. To AbbVie analyst Recommendation to compare Macroaxis buy or Sell? the lines at $ 104.27 and $ 103.52 its. Sell Recommendation with the highest probability of success | stock quotes by.! Much that it is nice to see insiders buying stock in the company to see insiders stock... Engages in the company support from the previous closing price of $ 112.50 18 Street! Chicago, IL holders are included in the large market cap category stock to behave and deviation! January 2021: Apple Triggers Sell signal Advisor, is AbbVie stock others... Of value, growth, and yield, making it a price-to-earnings ratio of 17.51 gives new the! • analyst recommendations • Related Companies boasts several additional promising drugs in pipeline! Out of a possible 100 score of 71 out of a possible 100 analyst... This gives new investors the opportunity to buy the stock sold off much that it is referred... Start trading today with zero commissions Instant ratings tool Financial information from.... Usually referred to as NYSE: ABBV or ABBV-N is AbbVie 's growth is 189.10B... Must note that the investments were made at well below today 's share price ABBV and start trading with. As you ’ d expect a pharmaceutical stock to behave stock in company. Been weighed down by other expense items, including goodwill impairment common questions ; How volatile are ABBV shares risky.